A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

10.1016/S1535-6108(02)00065-X

10.1056/NEJMra021902

10.1056/NEJM198902233200802

10.1016/S0140-6736(04)16981-X

10.1093/jnci/89.22.1673

10.1023/A:1006184428857

10.1023/A:1006141703224

10.1016/S0959-8049(99)00303-2

10.1186/bcr777

Fitzgibbons PL, 2000, Arch Pathol Lab Med, 124, 966, 10.5858/2000-124-0966-PFIBC

1996, J Clin Oncol, 14, 2843, 10.1200/JCO.1996.14.10.2843

Bast RC, 2001, J Clin Oncol, 19, 1865, 10.1200/JCO.2001.19.6.1865

Goldhirsch A, 2001, J Clin Oncol, 19, 3817, 10.1200/JCO.2001.19.18.3817

10.1093/jnci/93.13.979

Carlson RW, 2001, Cancer Control, 8, 54

10.1097/00062752-200207000-00011

10.1038/35021093

10.1126/science.286.5439.531

10.1038/415530a

10.1056/NEJMoa021967

10.1126/science.270.5235.467

10.1016/S0002-9440(10)63093-3

10.1073/pnas.191367098

Esteban J, 2003, Prog Proc Am Soc Clin Oncol, 22, 850

Cobleigh MA, 2003, Prog Proc Am Soc Clin Oncol, 22, 850

Paik S, 2003, Breast Cancer Res Treat, 82, A16

10.1111/j.1365-2559.1991.tb00229.x

10.2307/2290630

10.1002/sim.1061

Fisher B, 1990, J Clin Oncol, 8, 1005, 10.1200/JCO.1990.8.6.1005

Fisher B, 1983, J Clin Oncol, 1, 349, 10.1200/JCO.1983.1.6.349

10.1023/A:1020299707510

10.1016/0046-8177(95)90010-1

Hopton DS, 1989, Eur J Surg Oncol, 15, 21

10.1002/1097-0142(19861215)58:12<2662::AID-CNCR2820581219>3.0.CO;2-Y

Theissig F, 1990, Pathol Res Pract, 186, 732, 10.1016/S0344-0338(11)80263-3

10.1200/JCO.2002.02.026

Esteva FJ, 2003, Breast Cancer Res Treat, 82, A16